MAR-ALLOPURINOL DIN 02396343
Health Canada record
| Active ingredient(s) | ALLOPURINOL 300 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | M04AA01 ALLOPURINOL |
| Original market date | 17-Apr-2013 |
| Current status date | 17-Apr-2013 |
| Source | Health Canada DPD |
Establishment licence of the holder
Marcan Pharmaceuticals Inc. — licence 101909, currently licensed, last inspection rating C (2024-05-21).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ALLOPURINOL
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00555681 | ALLOPURINOL-100 | PRO DOC LIMITEE | Tablet | ALLOPURINOL 100 MG | Marketed |
| 02130157 | ALLOPURINOL-200 | PRO DOC LIMITEE | Tablet | ALLOPURINOL 200 MG | Marketed |
| 00555703 | ALLOPURINOL-300 | PRO DOC LIMITEE | Tablet | ALLOPURINOL 300 MG | Marketed |
| 00479799 | APO-ALLOPURINOL TABLETS | APOTEX INC | Tablet | ALLOPURINOL 200 MG | Marketed |
| 00402796 | APO-ALLOPURINOL TABLETS | APOTEX INC | Tablet | ALLOPURINOL 300 MG | Marketed |
| 00402818 | APO-ALLOPURINOL TABLETS | APOTEX INC | Tablet | ALLOPURINOL 100 MG | Marketed |
| 02395320 | IPG-ALLOPURINOL | MARCAN PHARMACEUTICALS INC | Tablet | ALLOPURINOL 100 MG | Approved |
| 02395347 | IPG-ALLOPURINOL | MARCAN PHARMACEUTICALS INC | Tablet | ALLOPURINOL 300 MG | Approved |
| 02395339 | IPG-ALLOPURINOL | MARCAN PHARMACEUTICALS INC | Tablet | ALLOPURINOL 200 MG | Approved |
| 02421615 | JAMP ALLOPURINOL | JAMP PHARMA CORPORATION | Tablet | ALLOPURINOL 300 MG | Marketed |
| 02421593 | JAMP ALLOPURINOL | JAMP PHARMA CORPORATION | Tablet | ALLOPURINOL 100 MG | Marketed |
| 02421607 | JAMP ALLOPURINOL | JAMP PHARMA CORPORATION | Tablet | ALLOPURINOL 200 MG | Marketed |
| 02396327 | MAR-ALLOPURINOL | MARCAN PHARMACEUTICALS INC | Tablet | ALLOPURINOL 100 MG | Marketed |
| 02396335 | MAR-ALLOPURINOL | MARCAN PHARMACEUTICALS INC | Tablet | ALLOPURINOL 200 MG | Marketed |
| 02481898 | AG-ALLOPURINOL | ANGITA PHARMA INC. | Tablet | ALLOPURINOL 300 MG | Cancelled Post Market |
| 02481863 | AG-ALLOPURINOL | ANGITA PHARMA INC. | Tablet | ALLOPURINOL 100 MG | Cancelled Post Market |
| 02481871 | AG-ALLOPURINOL | ANGITA PHARMA INC. | Tablet | ALLOPURINOL 200 MG | Cancelled Post Market |
| 00449687 | ALLOPRIN | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Tablet | ALLOPURINOL 100 MG | Cancelled Post Market |
| 00454354 | ALLOPRIN | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Tablet | ALLOPURINOL 300 MG | Cancelled Post Market |
| 00514209 | ALLOPRIN | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Tablet | ALLOPURINOL 200 MG | Cancelled Post Market |
| 00294322 | ALLOPURINOL | APOTEX INC | Tablet | ALLOPURINOL 300 MG | Dormant |
| 02232605 | ALLOPURINOL TABLETS 100MG | LABORATOIRES CONFAB INC | Tablet | ALLOPURINOL 100 MG | Cancelled Pre Market |
| 02232611 | ALLOPURINOL TABLETS 200MG | LABORATOIRES CONFAB INC | Tablet | ALLOPURINOL 200 MG | Cancelled Pre Market |
| 02232613 | ALLOPURINOL TABLETS 300MG | LABORATOIRES CONFAB INC | Tablet | ALLOPURINOL 300 MG | Cancelled Pre Market |
| 02402769 | APO-ALLOPURINOL | APOTEX INC | Tablet | ALLOPURINOL 100 MG | Dormant |
| 02402777 | APO-ALLOPURINOL | APOTEX INC | Tablet | ALLOPURINOL 200 MG | Dormant |
| 02402785 | APO-ALLOPURINOL | APOTEX INC | Tablet | ALLOPURINOL 300 MG | Dormant |
| 02534061 | JAMP ALLOPURINOL TABLETS | JAMP PHARMA CORPORATION | Tablet | ALLOPURINOL 300 MG | Cancelled Pre Market |
| 02534045 | JAMP ALLOPURINOL TABLETS | JAMP PHARMA CORPORATION | Tablet | ALLOPURINOL 100 MG | Cancelled Pre Market |
| 02534053 | JAMP ALLOPURINOL TABLETS | JAMP PHARMA CORPORATION | Tablet | ALLOPURINOL 200 MG | Cancelled Pre Market |
| 00364282 | NOVO-PUROL TAB 100MG | NOVOPHARM LIMITED | Tablet | ALLOPURINOL 100 MG | Cancelled Post Market |
| 00565342 | NOVO-PUROL TAB 200 MG | NOVOPHARM LIMITED | Tablet | ALLOPURINOL 200 MG | Cancelled Post Market |
| 00363693 | NOVO-PUROL TAB 300MG | NOVOPHARM LIMITED | Tablet | ALLOPURINOL 300 MG | Cancelled Post Market |
| 02348268 | NTP-ALLOPURINOL | TEVA CANADA LIMITED | Tablet | ALLOPURINOL 100 MG | Cancelled Pre Market |
| 02348276 | NTP-ALLOPURINOL | TEVA CANADA LIMITED | Tablet | ALLOPURINOL 200 MG | Cancelled Pre Market |
| 02348284 | NTP-ALLOPURINOL | TEVA CANADA LIMITED | Tablet | ALLOPURINOL 300 MG | Cancelled Pre Market |
| 02335840 | NU-ALLOPURINOL | NU-PHARM INC | Tablet | ALLOPURINOL 100 MG | Cancelled (Unreturned Annual) |
| 02335867 | NU-ALLOPURINOL | NU-PHARM INC | Tablet | ALLOPURINOL 300 MG | Cancelled (Unreturned Annual) |
| 02335859 | NU-ALLOPURINOL | NU-PHARM INC | Tablet | ALLOPURINOL 200 MG | Cancelled (Unreturned Annual) |
| 02471728 | PMS-ALLOPURINOL | PHARMASCIENCE INC | Tablet | ALLOPURINOL 300 MG | Cancelled Pre Market |
| 02471736 | PMS-ALLOPURINOL | PHARMASCIENCE INC | Tablet | ALLOPURINOL 200 MG | Cancelled Pre Market |
| 02471620 | PMS-ALLOPURINOL | PHARMASCIENCE INC | Tablet | ALLOPURINOL 100 MG | Cancelled Pre Market |
| 00415731 | PURINOL TAB 100MG | CARTER-HORNER CORP. | Tablet | ALLOPURINOL 100 MG | Cancelled Post Market |
| 00415758 | PURINOL TAB 200MG | CARTER-HORNER CORP. | Tablet | ALLOPURINOL 200 MG | Cancelled Post Market |
| 00415766 | PURINOL TAB 300MG | CARTER-HORNER CORP. | Tablet | ALLOPURINOL 300 MG | Cancelled Post Market |
| 02240843 | RIVA-PURINOL 100MG TABLETS | LABORATOIRE RIVA INC. | Tablet | ALLOPURINOL 100 MG | Cancelled Post Market |
| 02240844 | RIVA-PURINOL 200MG TABLETS | LABORATOIRE RIVA INC. | Tablet | ALLOPURINOL 200 MG | Cancelled Post Market |
| 02240845 | RIVA-PURINOL 300MG TABLETS | LABORATOIRE RIVA INC. | Tablet | ALLOPURINOL 300 MG | Cancelled Post Market |
| 00004588 | ZYLOPRIM 100 | GLAXOSMITHKLINE INC | Tablet | ALLOPURINOL 100 MG | Cancelled Post Market |
| 00506370 | ZYLOPRIM 200 | GLAXOSMITHKLINE INC | Tablet | ALLOPURINOL 200 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 13874 | 2012-11-22 | Abbreviated New Drug Submission (ANDS) | New manufacturer and product name |
International API supply for ALLOPURINOL
20 valid EDQM Certificates of Suitability from 19 holders. 17 active FDA Drug Master Files.
Request a quote for MAR-ALLOPURINOL